Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate CancerN. Engl. J. Med 2020 Jun 04;382(23)2187-2196, ND Shore, F Saad, MS Cookson, DJ George, DR Saltzstein, R Tutrone, H Akaza, A Bossi, DF van Veenhuyzen, B Selby, X Fan, V Kang, J Walling, B Tombal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.